Gene: SNX25
Official Full Name: sorting nexin 25provided by HGNC
Gene Summary: Predicted to enable phosphatidylinositol binding activity and type I transforming growth factor beta receptor binding activity. Involved in negative regulation of transforming growth factor beta receptor signaling pathway and receptor catabolic process. Located in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25325 | SNX25 Knockout cell line (HeLa) | Human | SNX25 | 1:3~1:6 | Negative | Online Inquiry |
KO25326 | SNX25 Knockout cell line (HCT 116) | Human | SNX25 | 1:2~1:4 | Negative | Online Inquiry |
KO25327 | SNX25 Knockout cell line (HEK293) | Human | SNX25 | 1:3~1:6 | Negative | Online Inquiry |
KO25328 | SNX25 Knockout cell line (A549) | Human | SNX25 | 1:3~1:4 | Negative | Online Inquiry |
SNX25 Gene Knockout Cell Lines are specifically engineered cellular models in which the SNX25 gene has been disrupted using CRISPR-Cas9 technology. These cell lines serve as invaluable tools for investigating the functional role of the SNX25 gene, which is implicated in intracellular trafficking, endosomal sorting, and protein turnover mechanisms. By creating a precise knockout of the SNX25 gene, researchers can explore the cellular consequences of its loss, thereby enhancing our understanding of various biological processes and pathways.
The primary function of SNX25 involves its role in the retromer complex, a critical component that mediates the recycling of proteins from endosomes back to the trans-Golgi network. The knockout of this gene leads to altered endocytic processes, thus enabling detailed studies into diseases associated with aberrant protein trafficking, including neurodegenerative disorders and cancers. Researchers can utilize these tools to verify hypotheses related to cellular pathways, providing insights that are essential for both basic research and the development of targeted therapeutics.
One of the distinctive advantages of SNX25 Gene Knockout Cell Lines is their ability to provide a consistent and reproducible model system, facilitating high-throughput screening for potential drug candidates that target specific biological pathways. Unlike traditional methods that involve transient gene silencing, these knockout lines offer a stable and permanent alteration, thereby enhancing the reliability of experimental results. Moreover, they are versatile and can be used with various assays such as western blotting, immunofluorescence, and genomic studies, allowing for a broad range of applications.
For researchers and clinicians alike, the SNX25 Gene Knockout Cell Lines are invaluable assets for investigating fundamental biological questions and for developing innovative strategies for disease intervention. The precision and reliability they offer can significantly advance projects aimed at understanding complex cellular mechanisms, ultimately contributing to groundbreaking research outcomes.
Our company specializes in the development of high-quality biological products, leveraging cutting-edge techniques and deep scientific expertise to create innovative tools that empower researchers worldwide. With a strong commitment to quality and customer support, we ensure that our products meet the rigorous standards required for impactful scientific research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.